Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2023-02-22 | Bokslutskommuniké 2022 |
| 2022-12-05 | Extra Bolagsstämma 2022 |
| 2022-07-21 | Kvartalsrapport 2022-Q2 |
| 2022-05-31 | Årsstämma 2022 |
| 2022-05-06 | Ordinarie utdelning KARO 0.00 SEK |
| 2022-02-25 | Bokslutskommuniké 2021 |
| 2021-10-28 | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | Kvartalsrapport 2021-Q2 |
| 2021-04-23 | Ordinarie utdelning KARO 0.00 SEK |
| 2021-04-21 | Kvartalsrapport 2021-Q1 |
| 2021-04-21 | Årsstämma 2021 |
| 2021-02-18 | Bokslutskommuniké 2020 |
| 2020-10-30 | Kvartalsrapport 2020-Q3 |
| 2020-07-21 | Kvartalsrapport 2020-Q2 |
| 2020-05-25 | Årsstämma 2020 |
| 2020-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2020-04-29 | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | Bokslutskommuniké 2019 |
| 2019-11-15 | Kvartalsrapport 2019-Q3 |
| 2019-09-20 | Extra Bolagsstämma 2019 |
| 2019-07-19 | Kvartalsrapport 2019-Q2 |
| 2019-05-17 | Ordinarie utdelning KARO 0.00 SEK |
| 2019-05-16 | Årsstämma 2019 |
| 2019-04-26 | Kvartalsrapport 2019-Q1 |
| 2019-02-14 | Bokslutskommuniké 2018 |
| 2018-11-01 | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | Ordinarie utdelning KARO 0.30 SEK |
| 2018-05-03 | Årsstämma 2018 |
| 2018-04-26 | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | Bokslutskommuniké 2017 |
| 2017-12-08 | Extra Bolagsstämma 2017 |
| 2017-11-02 | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | Ordinarie utdelning KARO 0.28 SEK |
| 2017-05-12 | Bonusutdelning KARO 0.22 |
| 2017-05-11 | Årsstämma 2017 |
| 2017-05-10 | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | Bokslutskommuniké 2016 |
| 2016-10-27 | Kvartalsrapport 2016-Q3 |
| 2016-07-15 | Kvartalsrapport 2016-Q2 |
| 2016-05-13 | Ordinarie utdelning KARO 0.00 SEK |
| 2016-05-12 | Kvartalsrapport 2016-Q1 |
| 2016-05-12 | Årsstämma 2016 |
| 2016-03-16 | Extra Bolagsstämma 2016 |
| 2016-02-12 | Bokslutskommuniké 2015 |
| 2015-10-29 | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | Split KARO 20:1 |
| 2015-07-10 | Kvartalsrapport 2015-Q2 |
| 2015-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2015-04-29 | Årsstämma 2015 |
| 2015-04-29 | Kvartalsrapport 2015-Q1 |
| 2015-02-13 | Bokslutskommuniké 2014 |
| 2014-10-29 | Kvartalsrapport 2014-Q3 |
| 2014-07-11 | Kvartalsrapport 2014-Q2 |
| 2014-05-09 | Ordinarie utdelning KARO 0.00 SEK |
| 2014-05-08 | Årsstämma 2014 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-03-17 | Extra Bolagsstämma 2014 |
| 2014-02-13 | Bokslutskommuniké 2013 |
| 2013-10-25 | Kvartalsrapport 2013-Q3 |
| 2013-07-12 | Kvartalsrapport 2013-Q2 |
| 2013-05-08 | Ordinarie utdelning KARO 0.00 SEK |
| 2013-05-07 | Kvartalsrapport 2013-Q1 |
| 2013-05-07 | Årsstämma 2013 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-12 | Bokslutskommuniké 2012 |
| 2013-02-12 | Analytiker möte 2013 |
| 2012-11-19 | Extra Bolagsstämma 2012 |
| 2012-10-24 | Kvartalsrapport 2012-Q3 |
| 2012-07-13 | Kvartalsrapport 2012-Q2 |
| 2012-06-12 | Årsstämma 2012 |
| 2012-04-30 | Ordinarie utdelning KARO 0.00 SEK |
| 2012-04-27 | Kvartalsrapport 2012-Q1 |
| 2012-02-08 | Bokslutskommuniké 2011 |
| 2011-11-29 | 15-7 2011 |
| 2011-10-25 | Kvartalsrapport 2011-Q3 |
| 2011-07-13 | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | Ordinarie utdelning KARO 0.00 SEK |
| 2011-04-27 | Årsstämma 2011 |
| 2011-04-27 | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | Bokslutskommuniké 2010 |
| 2010-10-26 | Kvartalsrapport 2010-Q3 |
| 2010-07-13 | Kvartalsrapport 2010-Q2 |
| 2010-04-26 | Ordinarie utdelning KARO 0.00 SEK |
| 2010-04-23 | Årsstämma 2010 |
| 2010-04-22 | Kvartalsrapport 2010-Q1 |
| 2010-02-09 | Bokslutskommuniké 2009 |
| 2009-10-22 | Kvartalsrapport 2009-Q3 |
| 2009-07-14 | Kvartalsrapport 2009-Q2 |
| 2009-04-27 | Ordinarie utdelning KARO 0.00 SEK |
| 2009-04-24 | Årsstämma 1 |
| 2009-04-22 | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Today, on 16 August 2022, Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma") to acquire the shares in Karo Pharma not already held by Karo Intressenter at a price of SEK 60 per share (the "Offer").
For further information about the Offer, please refer to Karo Intressenter's press release (https://news.cision.com/karo-intressenter-ab/r/karo-intressenter-ab-announces-a-public-cash-offer-to-the-shareholders-in-karo-pharma-aktiebolag,c3614453). Karo Intressenter is expected to publish an offer document regarding the Offer on 17 August 2022. The acceptance period for the Offer is expected to commence on 18 August 2022 and expire on 15 September 2022.
The board of directors of Karo Pharma has, in accordance with the Takeover rules for certain trading platforms, initiated the work on handling matters concerning the Offer, including to obtain a fairness opinion.
Roschier Advokatbyrå AB has been appointed as legal advisor.
The board of directors will revert well before and no later than two weeks prior to the expiry of the acceptance period in the Offer.
Stockholm, 16 August 2022
Karo Pharma Aktiebolag
For additional information, please contact:
Richard Edström, Head of Legal, +4670609 88 68, richard.edstrom@karopharma.com
This information is information that Karo Pharma Aktiebolag is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 16 August 2022, at 14:00 CEST.
About Karo Pharma
Karo Pharma offers "Smart choices for everyday healthcare". We own and commercialize reliable original brands within prescription drugs and over-the-counter consumer products. Our products are available in over 90 countries with the core in Europe and the Nordics region. The headquarter of Karo Pharma is in Stockholm and the company is listed on Nasdaq First North Growth Market.
[1] A Swedish private limited liability company (Sw. privat aktiebolag) controlled by EQT VIII, registered with the Swedish Companies Registration Office (Sw. Bolagsverket) with corporate registration number 559160-9416.